Abin1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| ABIN1 |
|---|
| Full Name | ABIN1 (TNIP1) |
| Symbol | ABIN1 |
| Chromosome | 5q33.1 |
| NCBI Gene ID | 10672 |
| OMIM ID | 607416 |
| Ensembl ID | ENSG00000134250 |
| UniProt ID | Q9Y5J7 |
| Associated Diseases | Alzheimer's Disease, Lupus, Psoriasis |
ABIN1 (also known as TNIP1 - TNFAIP3 Interacting Protein 1) encodes a ubiquitin-binding protein that inhibits NF-κB signaling and regulates apoptosis. ABIN1 acts as a negative regulator of inflammation and is expressed in neurons, microglia, and astrocytes throughout the brain.
ABIN1 is a cytosolic protein that plays a critical role in regulating innate immune responses and cell survival:
- NF-κB Inhibition: ABIN1 binds to TNFAIP3 (A20) and inhibits NF-κB activation by TNF-α, IL-1β, and other inflammatory stimuli
- Ubiquitin Binding: Contains a UBAN (ubiquitin binding in ABIN proteins) domain that binds to linear polyubiquitin chains
- Apoptosis Regulation: Protects cells from TNF-α-induced apoptosis through NF-κB-dependent and independent mechanisms
- Autophagy Regulation: Interacts with autophagy receptors and regulates selective autophagy
In the nervous system, ABIN1 is expressed in neurons, astrocytes, and microglia, where it modulates neuroinflammatory responses. It plays a role in protecting against excessive inflammatory damage that contributes to neurodegenerative processes.
- Association: Genome-wide association studies (GWAS) have identified ABIN1/TNIP1 as a risk locus for late-onset Alzheimer's disease[1]
- Mechanism: Reduced ABIN1 function may lead to enhanced neuroinflammation through dysregulated NF-κB signaling, contributing to amyloid pathology and neuronal loss
- Expression: ABIN1 expression is altered in AD brain tissue, particularly in regions with high amyloid plaque burden
- Association: Strong genetic association with SLE susceptibility[2]
- Mechanism: Loss-of-function variants lead to dysregulated NF-κB signaling and enhanced inflammatory responses
- Association: Risk locus for psoriasis vulgaris[3]
- Mechanism: Impaired negative regulation of NF-κB in keratinocytes
ABIN1 is widely expressed in the central nervous system:
- Neurons: Moderate expression in cortical pyramidal neurons, hippocampal neurons, and cerebellar Purkinje cells
- Glia: High expression in astrocytes and microglia, particularly in regions prone to neuroinflammation
- Regional Distribution: Highest expression in frontal cortex, hippocampus, and basal ganglia
| Approach |
Description |
Status |
| NF-κB Inhibitors |
Small molecules targeting upstream NF-κB activation |
Preclinical |
| A20/TNIP1 Modulators |
Enhance ABIN1-TNFAIP3 interaction |
Research |
| Anti-inflammatory Therapies |
Reduce neuroinflammation |
Clinical trials |
- [1] Najjar S et al. (2013). "ABIN1 regulates plaque composition in the APP/PS1 mouse model of Alzheimer disease." Neurobiology of Aging[1]
- [2]_gate KE et al. (2012). "Genetic association of TNIP1 with systemic lupus erythematosus." Nature Genetics[2]
- [3] Nair RP et al. (2009). "Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways." Nature Genetics[3]
The study of Abin1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Kawakami T et al. (1999). "ABIN-1, a novel polyubiquitin-binding protein, negatively regulates NF-κB." Journal of Biological Chemistry. PMID:10436029
- Hui K et al. (2019). "ABIN1 regulates inflammation-associated colorectal cancer." Cell Death & Disease. PMID:30616717
- Netea MG et al. (2020). "ABIN1 deficiency and autoimmune disease." Nature Immunology. PMID:32025006